Abolis develops high-impact innovations and provides tailor-made industrial solutions based on micro-organisms for various industries including food, healthcare, cosmetics, and chemistry.

Abolis Biotechnology

Abolis Biotechnologies | 7,616 followers on LinkedIn. Decipher - Innovate - Build | Abolis is a French company delivering high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms.
Founded in 2014, Abolis is made up of a team of over 54 people, sharing a scientific and humanist ambition.

VP Transformation & Operations Management | Business Value & Customer Centric Driven | Digital & Cloud Transformation Journey Advisor | Biotech

Frédéric Austruy

Damien Bourel

Fermentation Department Manager at Abolis Biotechnologies

Jean-Michel Bavouzet

Managing Partner at Figem

Dominique Megret

Abolis Biotechnologies

Réindustrialiser et décarboner l'industrie, deux objectifs atteignables grâce aux biotechnologies. Bpifrance La French Fab France Industrie

Thanks to Fiona Mischel and SynBioBeta for the article. Abolis will continue to develop its business in Cosmetics, Pharma, Food ingredients and chemicals.

Merci à Françoise de Vaugelas et Formule Verte pour cet échange. Les défis existent pour industrialiser les biotechnologies. Il y a déjà de beaux succès et de belles opportunités à venir, même si les développements ne sont pas de longs fleuves tranquilles. Gwenael Servant, PhD Microbiome Studio

Why microbes and biotechnologies are essential to our economy ? Because you can address the main challenges we are facing: health, food production, energy, materials. Take the time to read this very interesting paper: https://lnkd.in/e7Dr-H6N "Microorganisms, including bacteria, archaea, viruses, fungi, and protists, are essential to life on Earth and the functioning of the biosphere. Here, we discuss the key roles of microorganisms in achieving the United Nations Sustainable Development Goals (SDGs), highlighting recent and emerging advances in microbial research and technology that can facilitate our transition toward a sustainable future." Abolis Biotechnologies Microbiome Studio SICOS (chimie fine & biotech) Douglas Robinson

Gwenael Servant, PhD

Most of the people do not expect to be surrounded by chemistry, it's part of our everyday (comfortable) life. Many of those chemicals can be made using alternative processes. This is what we do @ Abolis Biotechnologies , we use biotechnology as a way to produce molecules, not from oil, but from non fossil feedstock, so that we can limit GHG emissions and carbon footprint of chemicals. Biotechnology is also an incredible tool to innovate (new molecules) or to reshore manufacturing. Contact us so that we can talk about it !

Want to know more about Abolis ? Check this video..... Abolis Biotechnologies Microbiome Studio

Cyrille PAUTHENIER était présent ce matin sur le plateau de BFM Business avec Laure Closier pour présenter ce qu'apportent les biotechnologies et la contribution d'Abolis à la décarbonation et la "défossilisation" de l'économie. Abolis Biotechnologies Microbiome Studio

We're thrilled to be announcing that we've secured funding from new investors to fuel our growth trajectory. BOLD Evonik Venture Capital DTCF | DeepTech & Climate Fonds Clay Capital fka VisVires New Protein Icos Capital LIBERSET

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 7, 2024 7:01 PM	a08c787a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 7, 2024 7:01 PM	aac37ddf
crunchbase trigger	general	Nov 25, 2024 9:09 AM	3eaf0385
crunchbase profile	general	Nov 25, 2024 10:11 AM	6a53410f
li profile	general	Nov 7, 2024 7:01 PM	4bf6dcb4
translate crunchbase fundingrounds	general
peers	general	Nov 7, 2024 7:01 PM	ff39bc90
news basic	general	Nov 7, 2024 7:01 PM	6f443b06
bundesanzeiger	filings
financials download nd	financials
private financials	financials

ABOL

FR:ABOLIS

Abolis Biotechnology